UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study

The Lancet (British edition), 2016-07, Vol.388 (10039), p.45-54

2016

Volltextzugriff (PDF)

Long-term treatment with romiplostim and treatment-free platelet responses in children with chronic immune thrombocytopenia

Haematologica (Roma), 2019-11, Vol.104 (11), p.2283-2291

2019

Volltextzugriff (PDF)

Value of inhaled corticosteroid therapy in long-term asthma management

P&T (Lawrenceville, N.J.), 2010-07, Vol.35 (7), p.377-416

Beam, Donald S

2010

Volltextzugriff (PDF)

Romiplostim treatment for children with immune thrombocytopenia: Results of an integrated database of five clinical trials

Pediatric blood & cancer, 2020-11, Vol.67 (11), p.e28630-n/a

2020

Volltextzugriff (PDF)

Updated Results from the Single-Arm, Open-Label, Long-Term Efficacy and Safety Study of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)

Blood, 2019-11, Vol.134 (Supplement_1), p.1095-1095

2019

Volltextzugriff (PDF)

Long‐term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2‐year results from two pivotal phase 3 studies

European journal of haematology, 2022-09, Vol.109 (3), p.205-214

2022

Volltextzugriff (PDF)

Safety and Efficacy of Romiplostim in over 200 Children with Immune Thrombocytopenia (ITP): Results of an Integrated Database of 5 Clinical Trials

Blood, 2018-11, Vol.132 (Supplement 1), p.2428-2428

2018

Volltextzugriff (PDF)

A single-arm, long-term efficacy and safety study of subcutaneous romiplostim in children with immune thrombocytopenia

Blood advances, 2023-02, Vol.7 (3), p.396-405

2023

Volltextzugriff (PDF)

Final Safety and Efficacy Data of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)

Blood, 2017-12, Vol.130, p.14-14

2017

Volltextzugriff (PDF)

A Single-Arm, Open-Label, Long-Term Efficacy and Safety Study of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)

Blood, 2017-12, Vol.130, p.2334-2334

2017

Volltextzugriff (PDF)

Safety and Efficacy of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)

Blood, 2016-12, Vol.128 (22), p.3738-3738

2016

Volltextzugriff (PDF)

Outcomes of Unrelated Umbilical Cord Blood Transplantation for X-Linked Adrenoleukodystrophy

Biology of blood and marrow transplantation, 2007-06, Vol.13 (6), p.665-674

2007

Volltextzugriff (PDF)

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety and Efficacy of Romiplostim in Children with Immune Thrombocytopenia (ITP)

Blood, 2015-12, Vol.126 (23), p.7-7

2015

Volltextzugriff (PDF)

Safety and Efficacy of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Pediatric Patients with Immune Thrombocytopenia (ITP)

Blood, 2015-12, Vol.126 (23), p.3467-3467

2015

Volltextzugriff (PDF)

A STUDY OF THE FIRM'S ADVERTISING EXPENDITURE

SHUFORD, DONALD BEAM

1961

Volltextzugriff (PDF)

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary

Journal of the American College of Cardiology, 2019-06, Vol.73 (24), p.3168-3209

2019

Volltextzugriff (PDF)

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Journal of the American College of Cardiology, 2019-06, Vol.73 (24), p.e285-e350

2019

Volltextzugriff (PDF)

Tumor-conditional anti-CTLA4 uncouples antitumor efficacy from immunotherapy-related toxicity

The Journal of clinical investigation, 2019-01, Vol.129 (1), p.349-363

2019

Volltextzugriff (PDF)

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Journal of the American College of Cardiology, 2019-06, Vol.73 (24), p.3168-3209

2019

Volltextzugriff (PDF)

COVID-19 host genetic risk study conducted at community pharmacies: Implications for public health, research and pharmacists’ scope of practice

Research in social and administrative pharmacy, 2023-10, Vol.19 (10), p.1360-1364

2023

Volltextzugriff (PDF)

Putative malignant hyperthermia mutation CaV1.1-R174W is insufficient to trigger a fulminant response to halothane or confer heat stress intolerance

The Journal of biological chemistry, 2023-08, Vol.299 (8), p.104992-104992, Article 104992

2023

Volltextzugriff (PDF)

ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement

Journal of the American College of Cardiology, 2012-05, Vol.59 (20), p.1812-1832

2012

Volltextzugriff (PDF)

1 – 25 von 70

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(62)

Publikationsform

Sprache

Englisch
(70)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study

Long-term treatment with romiplostim and treatment-free platelet responses in children with chronic immune thrombocytopenia

Value of inhaled corticosteroid therapy in long-term asthma management

Romiplostim treatment for children with immune thrombocytopenia: Results of an integrated database of five clinical trials

Updated Results from the Single-Arm, Open-Label, Long-Term Efficacy and Safety Study of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)

Long‐term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2‐year results from two pivotal phase 3 studies

Safety and Efficacy of Romiplostim in over 200 Children with Immune Thrombocytopenia (ITP): Results of an Integrated Database of 5 Clinical Trials

A single-arm, long-term efficacy and safety study of subcutaneous romiplostim in children with immune thrombocytopenia

Final Safety and Efficacy Data of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)

A Single-Arm, Open-Label, Long-Term Efficacy and Safety Study of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)

Safety and Efficacy of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Children with Immune Thrombocytopenia (ITP)

Outcomes of Unrelated Umbilical Cord Blood Transplantation for X-Linked Adrenoleukodystrophy

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Safety and Efficacy of Romiplostim in Children with Immune Thrombocytopenia (ITP)

Safety and Efficacy of Long-Term Open-Label Dosing of Subcutaneous (SC) Romiplostim in Pediatric Patients with Immune Thrombocytopenia (ITP)

A STUDY OF THE FIRM'S ADVERTISING EXPENDITURE

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Tumor-conditional anti-CTLA4 uncouples antitumor efficacy from immunotherapy-related toxicity

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

ACCF/AHA/AMA-PCPI 2011 Performance Measures for Adults With Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association―Physician Consortium for Performance Improvement

COVID-19 host genetic risk study conducted at community pharmacies: Implications for public health, research and pharmacists’ scope of practice

Putative malignant hyperthermia mutation CaV1.1-R174W is insufficient to trigger a fulminant response to halothane or confer heat stress intolerance

ACCF/AHA/AMA-PCPI 2011 performance measures for adults with heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures and the American Medical Association-Physician Consortium for Performance Improvement

Suchergebnisse filtern